Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA Tamoxifen GDSC1000 pan-cancer AAC 0.0045 0.9
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC 0.007 0.9
mRNA 17-AAG FIMM pan-cancer AAC -0.022 0.9
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.0047 0.9
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.0062 0.9
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0045 0.9
mRNA purmorphamine CTRPv2 pan-cancer AAC -0.0046 0.9
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0044 0.9
mRNA AZ-3146 CTRPv2 pan-cancer AAC -0.0042 0.9
mRNA UNC1215 GDSC1000 pan-cancer AAC -0.0041 0.9
Download CSV